Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have earned a consensus rating of “Hold” from the five ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company.
A number of equities research analysts have issued reports on the stock. KeyCorp reduced their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Jefferies Financial Group set a $17.50 price objective on shares of Stevanato Group in a research note on Tuesday, February 10th. Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Morgan Stanley reduced their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, March 6th. Finally, Weiss Ratings downgraded Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th.
Stevanato Group Price Performance
Stevanato Group (NYSE:STVN – Get Free Report) last issued its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The company had revenue of €273.57 million for the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.10 earnings per share. On average, equities research analysts expect that Stevanato Group will post 0.68 earnings per share for the current fiscal year.
Key Stevanato Group News
Here are the key news stories impacting Stevanato Group this week:
- Positive Sentiment: Stevanato posted first-quarter 2026 revenue of €273.6 million, up 7% year over year and 10% at constant currency, driven by high-value solutions growth. Article Title
- Positive Sentiment: The company’s Q1 earnings came in at about €0.11–€0.13 per share, with one report noting a beat versus the €0.12 consensus, helping support the stock’s rebound. Article Title
- Positive Sentiment: Stevanato maintained its 2026 revenue guidance of €1.260 billion to €1.290 billion, signaling confidence in demand and execution despite macro uncertainty. Article Title
- Positive Sentiment: Management highlighted progress toward RTU cartridge production beginning in early 2027, which could expand the company’s addressable market and support longer-term growth. Article Title
- Neutral Sentiment: The company also filed a Form 6-K and held its Q1 earnings call, which mainly provided additional detail on the quarterly update rather than new material surprises. Article Title
- Neutral Sentiment: Coverage on valuation after the recent share-price rebound suggests investors are now weighing whether the stock’s recovery has already priced in some of the near-term earnings improvement. Article Title
Institutional Trading of Stevanato Group
A number of hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its stake in shares of Stevanato Group by 10.8% in the 1st quarter. Royal Bank of Canada now owns 437,284 shares of the company’s stock valued at $8,930,000 after acquiring an additional 42,731 shares during the last quarter. Sei Investments Co. increased its holdings in Stevanato Group by 16.9% in the 2nd quarter. Sei Investments Co. now owns 231,244 shares of the company’s stock worth $5,649,000 after purchasing an additional 33,419 shares in the last quarter. Raymond James Financial Inc. increased its holdings in Stevanato Group by 21.2% in the 2nd quarter. Raymond James Financial Inc. now owns 567,803 shares of the company’s stock worth $13,871,000 after purchasing an additional 99,328 shares in the last quarter. Ameriprise Financial Inc. raised its position in Stevanato Group by 14.2% in the second quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock valued at $17,316,000 after purchasing an additional 87,942 shares during the last quarter. Finally, Bamco Inc. NY raised its position in Stevanato Group by 2.1% in the second quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock valued at $46,125,000 after purchasing an additional 39,528 shares during the last quarter.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Further Reading
- Five stocks we like better than Stevanato Group
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
